KOELIS

Stand B7-A8 / 14

2022 Edition

KOELIS

France

KOELIS has assisted physicians from around the world in their routine clinical practice since 2006, providing the latest technology for personalized prostate cancer management. Based in Grenoble with a subsidiary in USA, Germnay & Singapore, KOELIS has been featured in more than 80 clinical publications and has benefited to more than 350,000 patients on all continents. Focused on developing targeted and less invasive solutions, KOELIS innovates every day in collaboration with world-renown universities and hospitals to offer physicians the newest advances in imaging for delivering efficient and patient-tailored solutions.